Hem › Munhålecancer › Colorado › Colorado Springs
Kliniska studier för Munhålecancer i Colorado Springs, CO
3 studier för Munhålecancer söker deltagare vid platser i och runt Colorado Springs (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekryterarFas 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekryterarFas 2
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekryterarFas 2
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Munhålecancer-studier i andra städer
- Atlanta, GA9 studier
- St. Louis, MO8 studier
- New York City, NY8 studier
- Chicago, IL8 studier
- Durham, NC7 studier
- Houston, TX7 studier
- Pittsburgh, PA7 studier
- Kansas City, MO7 studier
- Ann Arbor, MI7 studier
- Milwaukee, WI7 studier
- Portland, OR7 studier
- Richmond, VA7 studier
Andra studier i Colorado Springs
- Ulcerös kolit14 studier
- Crohns sjukdom13 studier
- Prostatacancer12 studier
- Icke-småcellig lungcancer11 studier
- Lungcancer8 studier
- Bröstcancer7 studier
- Astma6 studier
- Tjocktarmscancer6 studier
- Kolorektal cancer6 studier
- Rektalcancer4 studier
- Överdriven sömnighet4 studier
- Inflammatorisk tarmsjukdom4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.